September 28, 2010
3:10-cv-04971
News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
A New Jersey federal judge on Thursday found that four generics makers infringed an AstraZeneca PLC patent on the anti-psychotic Seroquel XR, effectively clearing the path for AstraZeneca to sell the blockbuster drug without generic competition for the next five years.